NATURAL KILLER CELLS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Natural Killer Cells Market - Overview Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent cell-mediated cytotoxicity (ADCC) and as simple natural killer activity of these cells. Furthermore, lectin-like receptors are one of two complex families of membrane receptors that recognize carbohydrates expressed on all cells. Such receptor engages its ligand when a natural killer cell encounters any normal cell that leads to generation of signal triggered, which in turn stimulates the natural killer cells to carry out its process. Though natural killer cells are demonstrated to be critical elements in the early immune response to a large variety of intracellular pathogens, they are used in clinical applications for treating lymphomas and other disorders. This in turn is expected to favor growth of the natural killer cells market over the forecast period (2016–2024). Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/naturalkiller-cells-market-178 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Application of the cells in treatment of critical diseases is expected to favor growth of the natural killer cells market: • Natural killer cells play an important role in stem-cell transplantation in therapies involving such cells activating endogenous natural killer cells and may transfer exogenous cells through adoptive cell therapy (ACT) and hematopoietic stem cell transplantation (HSCT). According to National Center for Biotechnology Information, U.S. National Library of Medicine, in 2014, such therapies are less effective in eliminating cancer stem cells as revealed by various studies. • Destructive midline facial lesions have conventionally been referred to as lethal midline granuloma. In some patients, the common causative lesions are Wegener’s granulomatosis, sarcoidosis, conventional Sino-nasal diffuse large B cell, and lymphomas carcinomas. However, among patients from Asia and South America, such lesions often show atypical lymphoid cells. This in turn is projected to favor the market growth in the near future. Furthermore, pro-inflammatory cytokines are secreted by activated natural killer cells, which then trigger Perforin/Granzyme induced target cell lysis. Their specific attaching ability and ability to discard stressed cells are fueling adoption of natural cells therapy, which is projected to support growth of the natural killer cells market over the forecast period. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/178 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Developments • Key players in the market are focused on various business strategies research and development, in order gain competitive edge in the market. For instance, in June 2019, NantKwest, a U.S.-based immunotherapy company, announced the U.S. Food and Drug Administration (FDA) clearance for the company’s PD-L1 t-haNK investigational new drug application (IND). The program is now transitioned to firstin-human clinical trial in patients with locally or advanced metastatic solid cancers.
• Key players in the market are involved in various business strategies such as partnership and collaboration, in order provide novel products in the market. For instance, in March 2019, Phio Pharmaceuticals Corp., a U.S.-based pharmaceutical company, and Glycosystem Therapeutics BV, a Dutch biotech company, collaborated to explore potential synergies of using Phio’s self-delivering RNAi technology in combination with Glycosystem’s natural killer cell technology oNKord. • Major companies in the global market are involved in growth strategies such as gaining grants from various institutes, in order develop novel products. The companies are planning to use the funds to develop technology to predict the outcome of NK-Cell-based immunotherapy in patients with solid tumors. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buynow/178 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
© Coherent market Insights. All Rights Reserved